FDA approves Biotest’s plasma-derived treatment for immunodeficiencies 20-Jun-2024 By Clara Rodriguez Fernandez Biotest, a subsidiary of Grifols, has received FDA approval for Yimmugo, a treatment for primary antibody deficiency syndromes (PID)
Interview: Inborn errors of immunity and the newer therapies becoming available 03-Jan-2024 By Liza Laws Heather Stefanski joined NMDP/Be The Match in May, 2021 as vice president, medical services.
New approaches urged to boost collection of plasma in EU 15-Nov-2021 By Jane Byrne There is an urgent need to increase plasma donations in the EU, says the Plasma Protein Therapeutics Association (PPTA).